Regardless, the finding that CD4+ CTLs are predisposed to invoke B cells and mediate humoral immunity through CXCL13 expression emphasizes their central role in tumor immunity in addition to their CD8+ CTL counterparts. Here, CD8A is linked to neoplasm.